Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GB226 in alveolar soft part sarcoma
CTR20181169Phase 2Active
- Sponsor
- Jacobio Pharmaceuticals
- Start
- Aug 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of geptanolimab in alveolar soft part sarcoma (ASPS), sponsored by Jacobio Pharmaceuticals. Started Aug 2018; status: active.
02
Drugs
geptanolimab
03
Conditions
alveolar soft part sarcoma (ASPS)
Beyond the preview
Go deeper on CTR20181169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181169.